Institutional Ownership
Spyre Therapeutics Inc
CUSIP 00773J202COM NEWSYREQ1 2026
Insider Transactions
63
Form 4 lines on record
Reporting Insiders
10
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
4.86M
Open-market sale shares
Insider Transactions — Form 4
63 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jul 1, 2026 | Burrows Scott L | Chief Financial Officer | M · Option Exercise | 7.5K | $14.50 | $108.8K | 105.5K | SEC |
| 2 | Jul 1, 2026 | Burrows Scott L | Chief Financial Officer | S · Sell | 5.8K | $87.55 | $505.6K | 99.7K | SEC |
| 3 | Jul 1, 2026 | Burrows Scott L | Chief Financial Officer | S · Sell | 1.7K | $88.37 | $152.4K | 98.0K | SEC |
| 4 | Jul 1, 2026 | Burrows Scott L | Chief Financial Officer | M · Option Exercise | 7.5K | — | — | 352.4K | SEC |
| 5 | Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | M · Option Exercise | 8.3K | $27.46 | $228.9K | 8.3K | SEC |
| 6 | Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | S · Sell | 6.5K | $87.52 | $568.9K | 1.8K | SEC |
| 7 | Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | S · Sell | 1.8K | $88.34 | $162.0K | 0 | SEC |
| 8 | Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | M · Option Exercise | 8.3K | — | — | 305.0K | SEC |
| 9 | Jul 1, 2026 | Turtle Cameron | Chief Executive Officer | S · Sell | 10.2K | $87.44 | $889.8K | 587.4K | SEC |
| 10 | Jul 1, 2026 | Turtle Cameron | Chief Executive Officer | S · Sell | 4.2K | $88.12 | $373.1K | 583.1K | SEC |
53 more insider transactions on Premium
See the full Form 4 transaction history for Spyre Therapeutics Inc.
Unlock all transactions